Literature DB >> 27029417

Gelation Behavior of 5-Chloro-8-hydroxyquinoline, an Antituberculosis Agent in Aqueous Alcohol Solutions.

Erkki Kolehmainen1, Hannu Salo2, Jukka Korpela3.   

Abstract

It was shown that 5-chloro-8-hydroxyquinoline, an antituberculosis agent, gels aqueous alcohol solutions efficiently. Thermal stability and gel-to-sol transition temperature of 1% gel in CD₃OD/D₂O (2:1) was studied by ¹H-NMR. Fibrous structures of four xerogels have been characterized by scanning electron microscope.

Entities:  

Keywords:  5-chloro-8-hydroxyquinoline; Mycobacterium tuberculosis; gel

Year:  2012        PMID: 27029417      PMCID: PMC4790243          DOI: 10.3390/antibiotics1010017

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


1. Introduction

Tuberculosis (TB) is one of the most serious infectious diseases caused by a single pathogen. One-third of the human population is reported to be latently infected with Mycobacterium tuberculosis, and millions of lives are lost every year [1]. In addition to many known antituberculosis drugs in use [2], 5-chloro-8-hydroxyquinoline or 5-chloroquinol-8-ol (Cloxyquine) has shown to incur in vitro activities against Mycobacterium tuberculosis [3]. Also, 8-hydroxyquinoline itself is effective against Mycobacterium tuberculosis [4] and some derivatives are shown to act as antibacterial agents that target intra- and extracellular Gram-negative pathogens [5]. Further, a novel polymorph of 5-chloro-8-hydroxyquinoline with improved water solubility and faster dissolution rate has been reported which can improve the bioavailability of the drug [6]. In addition, tacrine-8-hydroxyquinoline hybrids have been shown to have potential as multifunctional agents for the treatment of Alzheimer’s disease and have copper(II) complexing properties [7]. It has also been recently shown that some related mixed ligand transition metal complexes have antituberculosis activity [8]. The importance of mixed ligand transition metal complexes in drug development is further, more generally, described [9,10] Drug resistance in Mycobacterium tuberculosis was shown to be related to pharmacokinetic/pharmacodynamic (PK/PD) factors [11]. Therefore the gelation ability of this potential drug in aqueous solution can be of extreme importance owing to its usability in controlled release applications [12]. In conjunction with our interest in low molecular weight supramolecular (self assembling) gelators [13] we are now reporting our study on the gelation behavior of 5-chloro-8-hydroxyquinoline in aqueous alcohol solutions. These gelation properties can probably be related also with the supramolecular synthon pattern in solid cloxiquine, reported recently [14]. We consider that these results can help in tailoring better drug delivery and pharmaceutical formulation combating tuberculosis.

2. Results and Discussion

Figure 1 shows the structure and numbering of 5-chloro-8-hydroxyquinoline.
Figure 1

The structure and numbering of 5-chloro-8-hydroxyquinoline.

The structure and numbering of 5-chloro-8-hydroxyquinoline. Table 1 lists the gelation data in various aqueous alcohol solutions at 295 K. The gel formation was observed by the test tube inversion method. Systematic temperature studies of all gels were not performed. However, for 1% 5-chloro-8-hydroxyquinoline gel in CD3OD/D2O (2:1) the gel-to-sol temperature was between +28 °C and +30 °C observed by 1H-NMR.
Table 1

Gelation data of 5-chloro-8-hydroxyquinoline (cloxiquine).

EntrySolvent system[cloxiquine] gel stability
11:1 EtOH/H2O1.0% very stable
21:1 EtOH/H2O0.75% stable
31:1 EtOH/H2O0.5% stable
41:2 EtOH/H2O1.0% stable
51:2 EtOH/H2O0.5% stable
61:2 EtOH/H2O0.2% poor
71:4 EtOH/H2O1.0% stable
82:1 MeOH/H2O1.0% very stable
92:1 MeOH/H2O0.75% stable
102:1 MeOH/H2O0.5% precipitate
111:2 MeOH/H2O1.0% precipitate
121:4 MeOH/H2O1.0% precipitate
132:1 1-PrOH/H2O1.0% precipitate
141:1 1-PrOH/H2O2.0% very stable
151:1 1-PrOH/H2O1.0% stable
161:1 1-PrOH/H2O0.75% poor
171:1 1-PrOH/H2O0.5% precipitate
181:2 1-PrOH/H2O1.0% stable
191:4 1-PrOH/H2O1.0% stable
201:4 1-PrOH/H2O0,5% stable
211:4 1-PrOH/H2O0.2% stable
221:4 1-PrOH/H2O0.1% stable
231:8 1-PrOH/H2O1.0% precipitate
241:10 1-PrOH/H2O1.0% precipitate
251:1 2-PrOH/H2O2.0% stable
261:1 2-PrOH/H2O1.0% stable
271:1 2-PrOH/H2O0.5% stable
281:1 2-PrOH/H2O0.2% poor
291:2 2-PrOH/H2O1% (g) stable
301:4 2-PrOH/H2O1% precipitate
Gelation data of 5-chloro-8-hydroxyquinoline (cloxiquine). As can be seen, increasing the concentration of 5-chloro-8-hydroxyquinoline results in a better stability of the formed gels. However, 5-chloro-8-hydroxyquinoline is not a real hydrogelator because increasing the water molar ratio generally results in a precipitate formation. In addition, the topography of the gels was characterized by the electron microscopy. Four xerogels have been characterized by scanning electron microscopy (SEM), as described in Figure 2, Figure 3, Figure 4, Figure 5.
Figure 2

SEM image of xerogel from 1:1 EtOH/water 1% gel.

Figure 3

SEM image of xerogel from 2:1 MeOH/water 1% gel.

Figure 4

SEM image of xerogel from 1:1 1-PrOH/water 2% gel.

Figure 5

SEM image of xerogel from 1:1 1-PrOH/water 1% gel.

SEM image of xerogel from 1:1 EtOH/water 1% gel. SEM image of xerogel from 2:1 MeOH/water 1% gel. SEM image of xerogel from 1:1 1-PrOH/water 2% gel. SEM image of xerogel from 1:1 1-PrOH/water 1% gel. As can be seen, SEM images 2–5 revealed the presence of long rod-like structures with variable rod diameters. However, there exists some variation in the width and the length of the rods. In xerogels from 1:1 EtOH/water 1% gel (Figure 2) and from 1:1 1-PrOH/water 1% gel (Figure 5) the width variation is clearly larger and the average widths is greater than in the others (Figure 3 and Figure 4) which also show less bundled structures. In all xerogels, rods reveal no or very weak branching and the overall structure can thus be considered as an open-type network. The fractures of the network seen in Figure 5 are probably due to the faster evaporation of the solvent. The gel-to-sol transformation was studied by variable temperature NMR. This technique was successfully used recently in gel-to-sol transformation studies [15]. Figure 6 describes 500 MHz 1H-NMR spectra of 1.0% 5-chloro-8-hydroxyquinoline in CD3OD/D2O (2:1) from +18 °C (bottom) to +30 °C (top) in 2 °C steps. As can be seen, a clear increase in the signal intensity happens between +28 °C and +30 °C. This means that the number of motionally limited or NMR “silent” molecules of the gel [16] decreases significantly between these two temperatures owing to the gel-to-sol transformation where the molecular motion of 5-chloro-8-hydroxyquinoline is no longer restricted. Although this gel-to-sol change happens below the physiological conditions this finding suggests that the gel stability could be improved by other modifications of solvent systems.
Figure 6

Variable temperature 500 MHz 1H-NMR spectra of 1.0% 5-chloro-8-hydroxy-quinoline in CD3OD/D2O (2:1) from +18 °C (bottom) to +30 °C (top) in 2 °C steps. The clearincrease in the signal intensity between +28 °C and +30 °C is due to the gel-to-sol transformation.

3. Experimental

5-Chloro-8-hydroxyquinoline (95%) was purchased from Sigma-Aldrich and used without purification because its 1H-NMR spectrum did not reveal any impurity signals [17]. All solvents were also from commercial sources and used as obtained. Deionized water was from our own laboratory. The samples were prepared by weighing an accurate amount of 5-chloro-8-hydroxyquinoline in a known volume of the solvent system in a test tube. After that the mixture was heated in a water bath until the solute dissolves. Then the test tube was closed and allowed to cool to room temperature. The gel formation was detected by the tube inversion technique as non-mobility of the sample and by visual inspection. Variable temperature 500 MHz 1H-NMR spectra of 1.0% 5-chloro-8-hydroxy-quinoline in CD3OD/D2O (2:1) from +18 °C (bottom) to +30 °C (top) in 2 °C steps. The clearincrease in the signal intensity between +28 °C and +30 °C is due to the gel-to-sol transformation. SEM images have been taken with Zeiss EVO 50 scanning electron microscope. In Figure 2, Figure 3, Figure 4, Figure 5 are also given the working distance 12.0 mm and acceleration voltage 19.99 kV. VT 1H-NMR spectra were run with Bruker Avance DRX 500 FT NMR spectrometer in CD3OD/D2O 2:1-mixture using 30° flip angle and 4 scans. The chemical shift scale is referenced to the trace signal of CHD2OD at 3.31 ppm from internal TMS.

4. Conclusions

It was shown that 5-chloro-8-hydroxyquinoline, an antituberculosis agent, efficiently gels aqueous alcohol solutions. A variable temperature 1H-NMR study reveals that the gel-to-sol transition of 1.0% 5-chloro-8-hydroxy-12-quinoline in CD3OD/D2O (2:1) happens between +28 °C and +30 °C. Although this gel-to-sol transition takes place below the physiological conditions, this finding suggests that the gel stability could be improved by other modifications of solvent systems. This finding can be useful for the drug delivery and preparation of pharmaceutical formulations of 5-chloro-8-hydroxyquinoline.
  9 in total

Review 1.  Supramolecular gels: functions and uses.

Authors:  Neralagatta M Sangeetha; Uday Maitra
Journal:  Chem Soc Rev       Date:  2005-08-23       Impact factor: 54.564

2.  Global epidemiology of tuberculosis.

Authors:  Christopher Dye
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

3.  Supramolecular medicinal chemistry: mixed-ligand coordination complexes.

Authors:  Zhenbo Ma; Brian Moulton
Journal:  Mol Pharm       Date:  2007-05-12       Impact factor: 4.939

4.  In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.

Authors:  Poonpilas Hongmanee; Kamolchanok Rukseree; Benjamas Buabut; Boontiwa Somsri; Prasit Palittapongarnpim
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

5.  Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.

Authors:  Crystal M Darby; Carl F Nathan
Journal:  J Antimicrob Chemother       Date:  2010-04-30       Impact factor: 5.790

6.  Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

Authors:  María Isabel Fernández-Bachiller; Concepción Pérez; Gema C González-Muñoz; Santiago Conde; Manuela G López; Mercedes Villarroya; Antonio G García; María Isabel Rodríguez-Franco
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

Review 7.  A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Curr Opin Pharmacol       Date:  2011-07-30       Impact factor: 5.547

8.  Supramolecular synthon pattern in solid clioquinol and cloxiquine (APIs of antibacterial, antifungal, antiaging and antituberculosis drugs) studied by ³⁵Cl NQR, ¹H-¹⁷O and ¹H-¹⁴N NQDR and DFT/QTAIM.

Authors:  Jolanta Natalia Latosińska; Magdalena Latosińska; Marzena Agnieszka Tomczak; Janez Seliger; Veselko Zagar
Journal:  J Mol Model       Date:  2010-11-16       Impact factor: 1.810

9.  Derivatives of 8-hydroxyquinoline--antibacterial agents that target intra- and extracellular Gram-negative pathogens.

Authors:  Per-Anders Enquist; Asa Gylfe; Ulrik Hägglund; Pia Lindström; Henrik Norberg-Scherman; Charlotta Sundin; Mikael Elofsson
Journal:  Bioorg Med Chem Lett       Date:  2012-04-06       Impact factor: 2.823

  9 in total
  2 in total

1.  In situ formation of steroidal supramolecular gels designed for drug release.

Authors:  Hana Bunzen; Erkki Kolehmainen
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

2.  Insight into the Molecular Interaction of Cloxyquin (5-chloro-8-hydroxyquinoline) with Bovine Serum Albumin: Biophysical Analysis and Computational Simulation.

Authors:  Kamonrat Phopin; Waralee Ruankham; Supaluk Prachayasittikul; Virapong Prachayasittikul; Tanawut Tantimongcolwat
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.